热门资讯> 正文
2023-03-22 15:30
Shares of Precipio, Inc. (NASDAQ:PRPO – Get Rating) passed below its two hundred day moving average during trading on Tuesday . The stock has a two hundred day moving average of $0.79 and traded as low as $0.59. Precipio shares last traded at $0.63, with a volume of 216,603 shares changing hands.
Separately, Alliance Global Partners dropped their price target on shares of Precipio from $6.30 to $2.85 in a research note on Friday, March 3rd.
Get Precipio alerts:The company has a debt-to-equity ratio of 0.01, a quick ratio of 1.53 and a current ratio of 1.68. The company has a market capitalization of $14.26 million, a price-to-earnings ratio of -1.20 and a beta of 2.29. The stock's fifty day simple moving average is $0.80 and its two-hundred day simple moving average is $0.79.
A hedge fund recently bought a new stake in Precipio stock. Virtu Financial LLC acquired a new stake in Precipio, Inc. (NASDAQ:PRPO – Get Rating) in the 4th quarter, according to its most recent Form 13F filing with the Securities & Exchange Commission. The institutional investor acquired 45,146 shares of the biotechnology company's stock, valued at approximately $25,000. Virtu Financial LLC owned 0.20% of Precipio at the end of the most recent quarter. 9.62% of the stock is currently owned by institutional investors and hedge funds.
(Get Rating)
Precipio, Incis a cancer diagnostics and reagent technology company, which provides diagnostic products and services to the oncology market. Its products include ICP, HemeScreen, and IV-Cell, and services include primary diagnostic, SmartPath, SmartGen, HemeScreen Panel, and ICE COLD-PCR. The company was founded on March 6, 1997 and is headquartered in New Haven, CT.
Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.